| Description | Divozilimab (BCD-132), a humanized monoclonal antibody targeting CD20 (CD20), is utilized in multiple sclerosis research [1]. |
| molecular weight | N/A |
| CAS | 2254061-60-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |
| Description | Divozilimab (BCD-132), a humanized monoclonal antibody targeting CD20 (CD20), is utilized in multiple sclerosis research [1]. |
| molecular weight | N/A |
| CAS | 2254061-60-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |